Innovative Softgel Technologies To Deliver Poorly Soluble Molecules

Source: Catalent
iStock-1296470938-OSD-solid dose-capsule-softgel

The eBook discusses how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules. It also presents how the lipid-based delivery provides a tool for highly potent, poorly soluble, and unstable APIs.


  • The rationale of using lipid-based formulations to improve the oral bioavailability of poorly soluble drugs
  • Converting from intravenous to oral dose
  • Incorporating macromolecules into softgels

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online